Archive: 27/05/2013
Valeant to buy Bausch + Lomb for $8.7B (Update)
Canadian drugmaker Valeant Pharmaceuticals said Monday that it will pay $8.7 billion to buy Bausch + Lomb, one of the world's best-known makers of contact lenses, in a massive expansion of Valeant's smaller ophthalmology ...
May 27, 2013
Doc: Face transplant patient making good progress
A surgeon who operated on Poland's first face transplant patient says the man is already practicing swallowing and making sounds.
May 27, 2013
More than one in five parents believe they have little influence in preventing teens from using illicit substances
A new report indicates that more than one in five parents of teens aged 12 to 17 (22.3 percent) think what they say has little influence on whether or not their child uses illicit substances, tobacco, or alcohol. This report ...
May 27, 2013
Encouraging data from stem cell trial in stroke patients as plans for Phase II progress
Encouraging interim data from the world's first clinical trial examining the safety of neural stem cell treatment in stroke patients has been reported by researchers ahead of an application for Phase II trials.
May 27, 2013
S. Korea's plastic surgery fad goes extreme
South Korea's obsession with plastic surgery is moving on from standard eye and nose jobs to embrace a radical surgical procedure that requires months of often painful recovery.
May 27, 2013
No new H7N9 cases in China for second week
No new human cases of the deadly H7N9 bird flu strain were recorded in China for the second week in a row, national health authorities said Monday, suggesting the outbreak has slowed.
May 27, 2013
Preterm birth affects ability to solve complex cognitive tasks, study shows
Being born preterm goes hand in hand with an increased risk for neuro-cognitive deficits. Psychologists from the Ruhr-Universität Bochum and the University of Warwick, UK have investigated the relation between the duration ...
May 27, 2013